Recapitulate AD pathologies in an age‐dependent manner in organoids derived from multiple fAD patients harboring APP duplication or PSEN1 mutation. Treatment of patient‐derived organoids with β‐ and γ‐secretase inhibitors significantly reduces amyloid and tau pathology. The gene discussed is APP; the disease is familial Alzheimer disease.